JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 19, 2007; DOI: 10.1124/jpet.107.123307


0022-3565/07/3223-1023-1035$20.00
JPET 322:1023-1035, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.123307v1
322/3/1023    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Routaboul, C.
Right arrow Articles by Décout, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Routaboul, C.
Right arrow Articles by Décout, J.-L.

CELLULAR AND MOLECULAR

Discovery of {alpha}-Aminoazaheterocycle-Methylglyoxal Adducts as a New Class of High-Affinity Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels

Christel Routaboul, Caroline Norez, Patricia Melin, Marie-Carmen Molina, Benjamin Boucherle, Florian Bossard, Sabrina Noel, Renaud Robert, Chantal Gauthier, Frédéric Becq, and Jean-Luc Décout

Département de Pharmacochimie Moléculaire, Centre National de la Recherche Scientifique/Université de Grenoble-Joseph Fourier, Grenoble, France (C.R., M.-C.M., B.B., J.-L.D.); Institut de Physiologie et Biologie Cellulaires, Université de Poitiers, Centre National de la Recherche Scientifique, Poitiers, France (C.N., P.M., S.N., R.R., Fr.B.); and Institut du thorax, Institut National de la Santé et de la Recherche Médicale Unité 533, Nantes, France (Fl.B., C.G.)

The cystic fibrosis transmembrane conductance regulator (CFTR) represents the main Cl channel in the apical membrane of epithelial cells for cAMP-dependent Cl secretion. Here we report on the synthesis and screening of a small library of nontoxic {alpha}-aminoazaheterocycle-methylglyoxal adducts, inhibitors of wild-type (WT) CFTR and G551D-, G1349D-, and F508del-CFTR Cl channels. In whole-cell patch-clamp experiments of Chinese hamster ovary (CHO) cells expressing WT-CFTR, we recorded rapid and reversible inhibition of forskolin-activated CFTR currents in the presence of the adducts 5a and 8a,b at 10 pM concentrations. Using iodide efflux experiments, we compared concentration-dependent inhibition of CFTR with glibenclamide (IC50 = 14.7 µM), 3-[(3-trifluoromethyl)phenyl]-5-[(4-carboxyphenyl-)methylene]-2-thioxo-4-thiazolidinone (CFTRinh-172) (IC50 = 1.2 µM), and {alpha}-aminoazaheterocycle-methylglyoxal adducts and identified compounds 5a (IC50 = 71 pM), 8a,b (IC50 = 2.5 nM), and 7a,b (IC50 = 3.4 nM) as the most potent inhibitors of WT-CFTR channels. Similar ranges of inhibition were also found when these compounds were evaluated on CFTR channels with the cystic fibrosis mutations F508del (in temperature-corrected human airway epithelial F508del/F508del CF15 cells)-, G551D-, and G1349D-CFTR (expressed in CHO and COS-7 cells). No effect of compound 5a was detected on the volume-regulated or calcium-regulated iodide efflux. Picomolar inhibition of WT-CFTR with adduct 5a was also found using a 6-methoxy-N-(3-sulfopropyl)-quinolinium fluorescent probe applied to the human tracheobronchial epithelial cell line 16HBE14o–. Finally, we found comparable inhibition by 5a or by CFTRinh-172 of forskolin-dependent short-circuit currents in mouse colon. To the best of our knowledge, these new nontoxic {alpha}-aminoazaheterocycle-methylglyoxal adducts represent the most potent compounds reported to inhibit CFTR chloride channels.


Received March 23, 2007; accepted June 19, 2007.

Address correspondence to: Dr. Jean-Luc Décout, Département de Pharmacochimie Moléculaire, Université de Grenoble, Centre National de la Recherche Scientifique, Bât. E, rue de la Chimie, BP 53, 38041 Grenoble Cedex 9, France. E-mail: jean-lucdecout{at}ujf-grenoble.fr




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
N. D. Sonawane, O. Zegarra-Moran, W. Namkung, L. J. V. Galietta, and A. S. Verkman
{alpha}-Aminoazaheterocyclic-Methylglyoxal Adducts Do Not Inhibit Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Activity
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 529 - 535.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Fuller, C. H. Thompson, Z.-R. Zhang, C. S. Freeman, E. Schay, G. Szakacs, E. Bakos, B. Sarkadi, D. McMaster, R. J. French, et al.
State-dependent Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels by a Novel Peptide Toxin
J. Biol. Chem., December 28, 2007; 282(52): 37545 - 37555.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.